ATE196010T1 - Zusammensetzung zur kalibrierung oder kontrolle zur verwendung in einem serologischen igm-test - Google Patents

Zusammensetzung zur kalibrierung oder kontrolle zur verwendung in einem serologischen igm-test

Info

Publication number
ATE196010T1
ATE196010T1 AT94201876T AT94201876T ATE196010T1 AT E196010 T1 ATE196010 T1 AT E196010T1 AT 94201876 T AT94201876 T AT 94201876T AT 94201876 T AT94201876 T AT 94201876T AT E196010 T1 ATE196010 T1 AT E196010T1
Authority
AT
Austria
Prior art keywords
control composition
igm
calibration
serological test
composition
Prior art date
Application number
AT94201876T
Other languages
English (en)
Inventor
T Philip Wong
Russell Allen Hammond
Original Assignee
Behring Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22182260&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE196010(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Behring Diagnostics Inc filed Critical Behring Diagnostics Inc
Application granted granted Critical
Publication of ATE196010T1 publication Critical patent/ATE196010T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G01N33/6857—Antibody fragments
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/967—Standards, controls, materials, e.g. validation studies, buffer systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/972—Modified antibody, e.g. hybrid, bifunctional
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/863—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgM
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/105831—Protein or peptide standard or control [e.g., hemoglobin, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/106664—Blood serum or blood plasma standard or control

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Volume Flow (AREA)
  • Motorcycle And Bicycle Frame (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT94201876T 1993-06-29 1994-06-29 Zusammensetzung zur kalibrierung oder kontrolle zur verwendung in einem serologischen igm-test ATE196010T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/084,014 US5478753A (en) 1993-06-29 1993-06-29 Positive calibrator/control composition for an IgM serology assay and an IgM serology assay

Publications (1)

Publication Number Publication Date
ATE196010T1 true ATE196010T1 (de) 2000-09-15

Family

ID=22182260

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94201876T ATE196010T1 (de) 1993-06-29 1994-06-29 Zusammensetzung zur kalibrierung oder kontrolle zur verwendung in einem serologischen igm-test

Country Status (5)

Country Link
US (1) US5478753A (de)
EP (1) EP0636886B1 (de)
AT (1) ATE196010T1 (de)
DE (1) DE69425709T2 (de)
ES (1) ES2151528T3 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0636247B1 (de) * 1993-02-17 1998-09-02 Dade Behring Inc. Verfahren und zusammensetzung zur verminderung der effekte von endogener alkalischer phosphatase
US6015662A (en) * 1996-01-23 2000-01-18 Abbott Laboratories Reagents for use as calibrators and controls
US6096268A (en) * 1997-10-31 2000-08-01 Dade Behring Inc. Chromogenic and turbidimetric assay device
EP1135684B1 (de) 1998-12-01 2006-01-11 Viral Antigens, Inc. VERBESSERTE SPEZIFITÄT IN DER DETEKTION DER ANTI-RUBELLA IgM ANTIKÖRPER
RU2206094C1 (ru) * 2001-10-31 2003-06-10 Уральский научно-исследовательский институт дерматовенерологии и иммунопатологии Способ диагностики in vitro ложноположительных реакций на сифилис, обусловленных антифосфолипидным синдромом
DE10250368A1 (de) * 2002-10-29 2004-05-19 Viramed Biotech Ag Mittel und Verfahren zur Diagnose einer Treponemainfektion
US20050048468A1 (en) * 2003-08-27 2005-03-03 Bio-Rad Laboratories, Inc. Multiconstituent liquid lgG and IgM calibrators
FR2874093B1 (fr) * 2004-08-03 2006-12-01 Inodiag Sa Methode et trousse de determination du statut vaccinal de personnes
ATE439594T1 (de) * 2003-12-24 2009-08-15 Inodiag Verfahren zur serologischen diagnose und bestimmung des immunisierungszustands unter einschluss verschiedener kontrollen
CN1924579A (zh) * 2005-07-04 2007-03-07 上海富纯中南生物技术有限公司 一种代替阳性血清用作诊断试剂标准品的交联复合物及其作为标准品的使用方法
US20100009389A1 (en) * 2008-07-14 2010-01-14 Masood Unnabi Khan Method of Making and Using Versatile Positive Controls and Antibody Detection Assays
WO2010024271A1 (ja) * 2008-08-27 2010-03-04 三菱化学メディエンス株式会社 修飾抗ヘパリン／pf4複合体抗体及びhit抗体標準品
CA2793959C (en) 2010-03-25 2019-06-04 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
CA2832109C (en) 2011-06-10 2021-07-06 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
EP2568289A3 (de) 2011-09-12 2013-04-03 International AIDS Vaccine Initiative Immunselektion von rekombinantem vesikulärem Stomatitisvirus mit Expression von HIV-1-Proteinen durch Breitbandneutralisierungs-Antikörper
US9402894B2 (en) 2011-10-27 2016-08-02 International Aids Vaccine Initiative Viral particles derived from an enveloped virus
ES2631608T3 (es) 2012-06-27 2017-09-01 International Aids Vaccine Initiative Variante de la glicoproteína Env del VIH-1
US20150065381A1 (en) 2013-09-05 2015-03-05 International Aids Vaccine Initiative Methods of identifying novel hiv-1 immunogens
US10058604B2 (en) 2013-10-07 2018-08-28 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
US10877031B2 (en) 2013-12-06 2020-12-29 Ortho-Clinical Diagnostics, Inc. Assay device having a wash port
CN103901218A (zh) * 2014-04-01 2014-07-02 苏州浩欧博生物医药有限公司 一种自身免疫抗原阳性血清的制备方法
CN103926396A (zh) * 2014-04-01 2014-07-16 苏州浩欧博生物医药有限公司 一种过敏原阳性血清的制备方法
US9880181B2 (en) 2014-10-17 2018-01-30 Hob Biotech Group Suzhou Co., Ltd. Method for preparation of purified autoimmune antigen positive serum
WO2016058237A1 (zh) * 2014-10-17 2016-04-21 苏州浩欧博生物医药有限公司 一种过敏原阳性血清的纯化制备方法
US10174292B2 (en) 2015-03-20 2019-01-08 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
US9931394B2 (en) 2015-03-23 2018-04-03 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
CN105628941B (zh) * 2015-12-22 2017-09-22 北京康彻思坦生物技术有限公司 一种IgM血清学检测质控物的制备方法
CN109828105B (zh) * 2019-02-23 2022-08-19 郑州伊美诺生物技术有限公司 一种人IgM阳性替代品的制备方法
US20230152336A1 (en) * 2020-04-24 2023-05-18 Siemens Healthcare Diagnostics Inc. Calibration and quality control reagents for use with immunoassays for antibodies and methods of production and use thereof
CN112269021B (zh) * 2020-12-21 2021-04-06 北京中关村水木医疗科技有限公司 IgM质控品及其制备方法
CN113049817A (zh) * 2021-03-17 2021-06-29 杭州启泰生物技术有限公司 一种新型冠状病毒2019-nCoV体外诊断标准品的制备方法
CN113049805B (zh) * 2021-03-22 2022-09-23 深圳市亚辉龙生物科技股份有限公司 抗体复合物及其制备方法、检测试剂盒

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4292403A (en) * 1978-08-24 1981-09-29 Akzona Incorporated Detection and/or determination of IgM, IgA, IgD and IgE immunoglobulins
US4433059A (en) * 1981-09-08 1984-02-21 Ortho Diagnostic Systems Inc. Double antibody conjugate
US5008183A (en) * 1988-05-10 1991-04-16 Bio-Research Laboratories, Inc. Assay system for detecting antibody and a method of producing non-human immune antibody
EP0456794A1 (de) * 1989-12-01 1991-11-21 PB Diagnostic Systems, Inc. Immuntest zur bestimmung von antikörpern gegen infektiöse krankheitserreger
GB9015908D0 (en) * 1990-07-19 1990-09-05 Celltech Ltd Multivalent immunoglobulin

Also Published As

Publication number Publication date
EP0636886B1 (de) 2000-08-30
EP0636886A2 (de) 1995-02-01
DE69425709T2 (de) 2001-03-29
ES2151528T3 (es) 2001-01-01
DE69425709D1 (de) 2000-10-05
US5478753A (en) 1995-12-26
EP0636886A3 (de) 1995-11-15

Similar Documents

Publication Publication Date Title
DE69425709D1 (de) Zusammensetzung zur Kalibrierung oder Kontrolle zur Verwendung in einem serologischen IgM-Test
ATE55489T1 (de) Hochspezifisches antiserum gegen prokollagenpeptid col 1 (typ iii) und prokollagen-peptid (typ iii), seine herstellung und verwendung.
FI895505A0 (fi) Menetelmä ja reagenssipakkaus endotoksiinin tai endotoksiinin kaltaisen aineen määrittämiseksi näytteestä sekä menetelmässä käytettäväksi tarkoitetut monoklonaaliset vasta-aineet
EP0375422A3 (de) Zusammensetzung und Methoden zur Bestimmung der Anwesenheit von Amphetaminen in einer Probe, die in Verdacht steht, Amphetamine und/oder Metamphetamine zu enthalten
DE68924878D1 (de) Bestimmung eines felinen pathogen-specifischen Antikörpers und eines felinen pathogenen Antigens in einem Immuntest.
DE58902586D1 (de) Immunoassay und -rolymere igg-derivate zur kompensation von stoerfaktoren in immunoassays.
Bianchi et al. The use of a double antibody sandwich ELISA and monoclonal antibodies for the assessment of porcine IgM, IgG and IgA concentrations
Aga et al. Environmental immunoassays: alternative techniques for soil and water analysis
DE69230917D1 (de) Verfahren zur detektion von hepatitis c
DE69819643D1 (de) Zwei-Inkubations mit markiertem Antigen verwendenes Immunoassay
ES2023868B3 (es) Procedimiento de determinacion inmunometrico
KR960014336A (ko) 사람 글리센틴에 대한 모노클로날 항체, 이러한 항체를 생성하기 위한 하이브리도마 및 상기 항체를 사용한 사람 글리센틴의 검정방법
DE60323105D1 (de) Verfahren zur beseitigung von störungen in immunochromatographischen assays
AU635243B2 (en) Immunoassay of human osteocalcin, reagent and kit therefor, antihuman osteocalcin antibody, hybridoma producing said antibody, and method of producing said antibody
ATE102357T1 (de) Verfahren zur bestimmung von fuer ein antigen klassenspezifischen antikoerpern und dazu geeignetes reagenz.
DE3686717D1 (de) Immuntestverfahren.
ATE286596T1 (de) Chemische modifikation von antikörpern und antigenen
ATE174688T1 (de) Verfahren zur bestimmung von antigenen oder antikörpern in gegenwart eines immunkomplexes
DE69430500D1 (de) Chemilumineszierende Derivate mit langer Emissionswellenlänge und ihre Verwendung in Assays
DE59610859D1 (de) Immunologische Bestimmungsmethode
ATE281471T1 (de) Antikörper-testbesteck zur bestimmung von amylin
ATE119672T1 (de) Diagnostischer test für pseudomonas aeruginosa infektionen.
ES2076416T3 (es) Realizacion de un inmunoensayo segun el principio de la aglutinacion.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties